Table 1.

Characteristics of primary tumors used in study

Tumor sampleSubgroupINSSHistopathology *
T-203HYP2bFavorable
T-238HYP1Favorable
T-269HYP2aFavorable
T-1251HYP1Favorable
T-1253HYP1Favorable
T-1354HYP1Favorable
T-296HYP2aUnfavorable
T-347HYP1Favorable
T-25HYP1Favorable
T-1HYP2Favorable
T-36HYP2aFavorable
T-13611q−4Unfavorable
T-28311q−4Unfavorable
T-110011q−4Unfavorable
T-119411q−4Unfavorable
T-122011q−4Unfavorable
T-135211q−4Unfavorable
T-135911q−4Unfavorable
T-101211q−4Unfavorable
T-35511q−4Favorable
T-120011q−4Favorable
T-3111q−4Unfavorable
T-4811q−4Unfavorable
T-433MNA4Unfavorable
T-493MNA4Unfavorable
T-1009MNA4Unfavorable
T-1034MNA4Unfavorable
T-1198MNA4Unfavorable
T-1266MNA4Unfavorable
T-1068MNA4Unfavorable
T-1109MNA4Unfavorable
T-14MNA4Unfavorable
T-39MNA4Unfavorable
T-53MNA2Unfavorable
T-1406MNA2aUnfavorable
  • Abbreviations: HYP, hyperdiploid; 11q−, loss of 11q; INSS, International Neuroblastoma Staging System.

  • * Histopathology classification using Shimada system based on patient age at diagnosis, degree of differentiation, and mitosis-karyorrhexis index.